Highlights and Quick Summary
- Investing cash flow for the quarter ending June 30, 2023 was $12 Million (a -39.28% decrease compared to previous quarter)
- Year-over-year quarterly Investing cash flow decreased by -118.9%
- Annual Investing cash flow for 2022 was $-221 Million (a 311.95% increase from previous year)
- Annual Investing cash flow for 2021 was $-53.6 Million (a 59.84% increase from previous year)
- Twelve month Investing cash flow ending June 30, 2023 was $-32.7 Million (a -83.77% decrease compared to previous quarter)
- Twelve month trailing Investing cash flow decreased by -87.88% year-over-year
Trailing Investing cash flow for the last four month:
| 30 Jun '23 | 31 Mar '23 | 31 Dec '22 | 30 Sep '22 |
|---|---|---|---|
| $-32.7 Million | $-202 Million | $-221 Million | $-270 Million |
Visit stockrow.com/DSGN
for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow
statement with 10 years of data, and state-of-the-art screener.
Historical Investing cash flow of Design Therapeutics, Inc.
Most recent Investing cash flowof DSGN including historical data for past 10 years.Interactive Chart of Investing cash flow of Design Therapeutics, Inc.
Design Therapeutics, Inc. Investing cash flow for the past 10 Years (both Annual and Quarterly)
(All values are in $ million)
| Year | Q1 | Q2 | Q3 | Q4 | Fiscal Year |
|---|---|---|---|---|---|
| 2023 | $11.98 | $19.73 | – | – | – |
| 2022 | $-1.06 | $-63.39 | $-156.96 | $0.41 | $-220.99 |
| 2021 | $-50.06 | $-5.04 | $-21.57 | $23.03 | $-53.64 |
| 2020 | $2.0 | $3.19 | $0.5 | $-39.25 | $-33.56 |
Business Profile of Design Therapeutics, Inc.
Sector: Healthcare
Industry: Biotechnology